These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31381847)

  • 1. A Randomized, Crossover, Pharmacokinetics Evaluation of a Novel Continuous Release and Absorption Melatonin Formulation.
    Seiden DJ; Shah SM
    Prim Care Companion CNS Disord; 2019 Aug; 21(4):. PubMed ID: 31381847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and Safety of Intravenous, Intravesical, Rectal, Transdermal, and Vaginal Melatonin in Healthy Female Volunteers: A Cross-Over Study.
    Zetner D; Andersen LPK; Alder R; Jessen ML; Tolstrup A; Rosenberg J
    Pharmacology; 2021; 106(3-4):169-176. PubMed ID: 32937627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of oral and intravenous melatonin in healthy volunteers.
    Andersen LP; Werner MU; Rosenkilde MM; Harpsøe NG; Fuglsang H; Rosenberg J; Gögenur I
    BMC Pharmacol Toxicol; 2016 Feb; 17():8. PubMed ID: 26893170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized, Double-Blind, Crossover Study to Investigate the Pharmacokinetics of Extended-Release Melatonin Compared to Immediate-Release Melatonin in Healthy Adults.
    Mun JG; Wang D; Doerflein Fulk DL; Fakhary M; Gualco SJ; Grant RW; Mitmesser SH
    J Diet Suppl; 2024; 21(2):182-194. PubMed ID: 37150895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder.
    Maras A; Schroder CM; Malow BA; Findling RL; Breddy J; Nir T; Shahmoon S; Zisapel N; Gringras P
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):699-710. PubMed ID: 30132686
    [No Abstract]   [Full Text] [Related]  

  • 6. [Melatonin for children with insomnia].
    Berring-Uldum A; Debes NMM; Pedersen CR; Holst H
    Ugeskr Laeger; 2018 May; 180(19):. PubMed ID: 29761771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities.
    Wasdell MB; Jan JE; Bomben MM; Freeman RD; Rietveld WJ; Tai J; Hamilton D; Weiss MD
    J Pineal Res; 2008 Jan; 44(1):57-64. PubMed ID: 18078449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin prolonged release: in the treatment of insomnia in patients aged ≥55 years.
    Lyseng-Williamson KA
    Drugs Aging; 2012 Nov; 29(11):911-23. PubMed ID: 23044640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood.
    Serfaty MA; Osborne D; Buszewicz MJ; Blizard R; Raven PW
    Int Clin Psychopharmacol; 2010 May; 25(3):132-42. PubMed ID: 20195158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin Bioavailability After Oral Administration of a New Delayed-Release Form in Healthy Male Volunteers.
    Ait Abdellah S; Gal C; Guinobert I; Bardot V; Raverot V; Vitacca A; Blondeau C; Claustrat B
    Drugs R D; 2024 Sep; 24(3):415-423. PubMed ID: 39174857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of high-dose intravenous melatonin in humans.
    Andersen LP; Werner MU; Rosenkilde MM; Fenger AQ; Petersen MC; Rosenberg J; Gögenur I
    J Clin Pharmacol; 2016 Mar; 56(3):324-9. PubMed ID: 26184078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of Melatonin after Administration of an Oral Prolonged-Release Tablet and an Immediate-Release Sublingual Spray in Healthy Male Volunteers.
    Ait Abdellah S; Raverot V; Gal C; Guinobert I; Bardot V; Blondeau C; Claustrat B
    Drugs R D; 2023 Sep; 23(3):257-265. PubMed ID: 37438493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and functionality of OROS melatonin in healthy subjects.
    Shah J; Langmuir V; Gupta SK
    J Clin Pharmacol; 1999 Jun; 39(6):606-12. PubMed ID: 10354964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of topical application of melatonin cream 12.5% on cognitive parameters: A randomized, placebo-controlled, double-blind crossover study in healthy volunteers.
    Scheuer C; Pommergaard HC; Rosenberg J; Gögenur I
    J Dermatolog Treat; 2016 Nov; 27(6):488-494. PubMed ID: 27052036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers.
    Yoon S; Lee H; Kim TE; Lee S; Chee DH; Cho JY; Yu KS; Jang IJ
    Drug Des Devel Ther; 2014; 8():123-8. PubMed ID: 24470753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial.
    Gringras P; Gamble C; Jones AP; Wiggs L; Williamson PR; Sutcliffe A; Montgomery P; Whitehouse WP; Choonara I; Allport T; Edmond A; Appleton R;
    BMJ; 2012 Nov; 345():e6664. PubMed ID: 23129488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N
    BMC Med; 2010 Aug; 8():51. PubMed ID: 20712869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder.
    Gringras P; Nir T; Breddy J; Frydman-Marom A; Findling RL
    J Am Acad Child Adolesc Psychiatry; 2017 Nov; 56(11):948-957.e4. PubMed ID: 29096777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin Supplementation for Children With Atopic Dermatitis and Sleep Disturbance: A Randomized Clinical Trial.
    Chang YS; Lin MH; Lee JH; Lee PL; Dai YS; Chu KH; Sun C; Lin YT; Wang LC; Yu HH; Yang YH; Chen CA; Wan KS; Chiang BL
    JAMA Pediatr; 2016 Jan; 170(1):35-42. PubMed ID: 26569624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.